Alembic Pharmaceuticals has achieved a pivotal milestone with the final green light from the US health authority for its generic Sumatriptan autoinjector. This achievement signifies the company's inaugural foray into drug-device combo products, aimed at alleviating the agonizing symptoms of migraines and cluster headaches.